(Q47850544)

6 February 2018

review article

1 reference

title

Dehydroepiandrosterone (DHEA) and systemic lupus erythematosus. (English)

1 reference

6 February 2018

author name string

R H Derksen

series ordinal

1

1 reference

6 February 2018

publication date

1 June 1998

1 reference

6 February 2018

Seminars in Arthritis and Rheumatism

published in

1 reference

6 February 2018

volume

27

1 reference

6 February 2018

page(s)

335-347

1 reference

6 February 2018

issue

6

1 reference

6 February 2018

Sex steroids and the rheumatic diseases

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Low plasma androgens in women with active or quiescent systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Systemic Lupus Erythematosus in Males

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Dehydroepiandrosterone (DHEA): a fountain of youth?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Physiological importance of dehydroepiandrosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Adrenal glands of mouse and rat do not synthesize androgens

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Dehydroepiandrosterone (DHEA)--the "mother steroid". I. Immunologic action

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Physicochemical characterization of [3H] DHEA binding in rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

The presence of a dehydroepiandrosterone-specific receptor binding complex in murine T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Dehydroepiandrosterone sulfate, incidence of myocardial infarction, and extent of atherosclerosis in men

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Dehydroepiandrosterone sulfate and the risk of myocardial infarction in US male physicians: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Adrenal androgens and testosterone as coronary risk factors in the Helsinki Heart Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate in patients undergoing diagnostic coronary angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Effect of genetic background on the therapeutic effects of dehydroepiandrosterone (DHEA) in diabetes-obesity mutants and in aged normal mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Effects of dehydroepiandrosterone acetate on metabolism, body weight and composition of male and female rats

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Divergent correlations of circulating dehydroepiandrosterone sulfate and testosterone with insulin levels and insulin receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Failure of dehydroepiandrosterone to influence energy and protein metabolism in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Replacement of dehydroepiandrosterone enhances T-lymphocyte insulin binding in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

The relationship between sex steroids and bone mineral content in women soon after the menopause

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

The relation between calcium absorption, serum dehydroepiandrosterone, and vertebral mineral density in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

A prospective study of dehydroepiandrosterone sulfate (DHEAS) and bone mineral density in older men and women

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Sex hormone status and osteoporosis in postmenopausal women with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Depressed levels of dehydroepiandrosterone sulphate in postmenopausal women with rheumatoid arthritis but no relation with axial bone density

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Neuro-steroids: 3 beta-hydroxy-delta 5-derivatives in rat and monkey brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Receptor binding and electrophysiological effects of dehydroepiandrosterone sulfate, an antagonist of the GABAA receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Suppressive effects of dehydroepiandrosterone and 3β-methyl-androst-5-en-17-one on attack towards lactating female intruders by castrated male mice. II. Brain neurosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Plasma dehydroepiandrosterone sulfate in nursing home men.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Reduced plasma dehydroepiandrosterone concentrations in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Immune senescence and adrenal steroids: immune dysregulation and the action of dehydroepiandrosterone (DHEA) in old animals

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Reciprocal change with age in antibody to extrinsic and intrinsic antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Peritoneal Ly-1 B cells: genetic control, autoantibody production, increased lambda light chain expression

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Reversal of the immunosenescent phenotype by dehydroepiandrosterone: hormone treatment provides an adjuvant effect on the immunization of aged mice with recombinant hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Regulation of murine lymphokine production in vivo. II. Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Induction of TH1 and TH2 responses: a key role for the 'natural' immune response?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Low serum levels of dehydroepiandrosterone may cause deficient IL-2 production by lymphocytes in patients with systemic lupus erythematosus (SLE)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Dehydroepiandrosterone protects mice from endotoxin toxicity and reduces tumor necrosis factor production

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Reduction in the incidence and severity of collagen-induced arthritis in DBA/1 mice, using exogenous dehydroepiandrosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Postmenopausal steroid replacement with micronized dehydroepiandrosterone: preliminary oral bioavailability and dose proportionality studies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

An open study of dehydroepiandrosterone in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Changes in androgens during treatment with four low-dose contraceptives.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

The functions of corticosteroid-binding globulin and sex hormone-binding globulin: recent advances

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Dehydroepiandrosterone in systemic lupus erythematosus. Results of a double-blind, placebo-controlled, randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Prevention of autoantibody formation and prolonged survival in New Zealand black/New Zealand white F1 mice fed dehydroisoandrosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Increased oxidation of testosterone in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Low plasma androgens in women with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Alterations of estrogen metabolism in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

The bimodal mortality pattern of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Risk factors for coronary artery disease in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Clinical features of systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

The contributions of disease activity, sleep patterns, and depression to fatigue in systemic lupus erythematosus. A proposed model

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Th1 and Th2 cells in autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10:interferon-gamma-secreting cells in the peripheral blood

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Effects of antirheumatic agents on cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980013-9

7 January 2021

10.1016/S0049-0172(98)80013-9

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

9662752

1 reference

6 February 2018